Delivery Order SPE2DB24D9223-SPE2DB25FKEFL

Award Date 5/6/25
Potential Completion Date 5/28/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,568,196,669 units of BOTOX 200 unit vials, with a ceiling value of $3,672.40. The contract has a period of performance through May 28, 2025 and is a firm fixed-price delivery order. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,568,250 units of BOTOX 200 UNIT VIALS, with a ceiling value of $11,017.20 and a completion date of June 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026, which allows the...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4,556,763,691 units of Botox 100 unit vials, with a total ceiling value of $44,087.00. The contract has a firm fixed price pricing type and a completion date of April 19, 2022. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,590.50, is for the delivery of 4,568,120,444 units of Botox 200 unit vials. The contract has an ultimate completion date of May 16, 2025 and was awarded on April 25, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,326.26 firm fixed-price contract is for the delivery of 4,568,012,843 units of Botox 100 unit vials, with a completion date of May 12, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,181.00, is for the delivery of 4,568,188,603 units of Botox 200 unit vials. The contract has an ultimate completion date of May 8, 2025 and was awarded on April 17, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,568,382,131 units of Botox 100 unit vials, with a ceiling value of $9,251.40 and a completion date of June 12, 2025. The contract is not associated with a set-aside program. DMS Pharmaceutical Group Inc. holds a significant single-award...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,568,311,214 units of Botox 100 unit vials, with a ceiling value of $48,569.85 and a performance period extending to June 10, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,836.20, is for the delivery of 4,568,227,157 units of Botox 200 unit vials, with a completion date of May 19, 2025. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $48,569.85 contract is for the delivery of 4,568,360,804 vials of Botox 100 unit medication. The contract has an ultimate completion date of June 11, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under...
  • SPE2DB24D9223
    Indefinite Delivery Contract
  • SPE2DB24D9223-SPE2DB25FKEFL
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,568,196,648 units of Botox 200 unit vials, with a ceiling value of $11,017.20. The contract has a firm fixed price and an ultimate completion date of May 28, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide.

Generated 8/10/25, 1:26 AM